Zealand Pharma A/S
ZLDPF
$65.16
$1.802.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -53.35% | -36.07% | 28.21% | 35.56% | 40.83% |
| Total Depreciation and Amortization | 14.44% | 38.78% | 69.27% | 7,123.98% | -- |
| Total Amortization of Deferred Charges | 1,264.45% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -102.09% | -44.60% | -54.95% | -35.95% | 48.18% |
| Change in Net Operating Assets | 140.39% | 195.39% | 191.02% | 350.59% | 251.49% |
| Cash from Operations | -118.54% | 7.61% | 32.77% | 43.29% | 54.52% |
| Capital Expenditure | 10.69% | -42.93% | -56.05% | -55.90% | 2.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -581.32% | -658.25% | -24.33% | -10,311.18% | -374.69% |
| Cash from Investing | -575.29% | -651.61% | -13.53% | -2,813.14% | -483.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 96.97% | 96.19% | 96.61% | -21.12% | -20.81% |
| Issuance of Common Stock | 445.00% | 262.12% | 263.04% | 169.21% | 44.19% |
| Repurchase of Common Stock | -745.75% | -745.75% | -94.78% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -229.00% | -114.49% | -112.36% | -100.31% | -51.85% |
| Cash from Financing | 804.10% | 406.92% | 432.65% | 366.37% | 66.66% |
| Foreign Exchange rate Adjustments | 186.57% | 77.86% | 123.34% | 125.68% | -146.82% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.74% | 91.63% | 2,686.92% | 49.26% | -609.08% |